How a Congressional Defeat Could Translate into a Win for Patients

\n\nThe never-ending fight over whether or not Medicare will be able to negotiate down the price of drugs with the pharmaceutical companies who create them appears to be suffering another setback.Moderate Democratsare balking and it’s increasingly unlikely that party leadership will get the votes needed to pass this part of the proposed $3.5 trillion reconciliation package.

Read the source article at Managed Healthcare Executive
2021-10-05 00:22:00